[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_1891 

# __Variation in protection against re-infections__

## Articles mentionning the risk

* [Contributions to the mitigation of the COVID-19 pandemic](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_245.md)

## Category to which it belongs

* [The spread of infectious diseases and lack of understanding of transmission mechanisms contribute to the propagation of contagions, posing a global threat.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_55.md)

## Closest similar item

* [Disease severity in re-infected patients](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2461.md)
* [Infection control](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2382.md)
* [Infection prevention](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3124.md)
* [Infection risk](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2298.md)
* [Infections](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1890.md)
* [Poor infection control practices](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1751.md)
* [Under-ascertainment of infections](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_586.md)
* [Underreporting of infections](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1480.md)
* [Unknown effects of policies on infection rates](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3397.md)
* [Unreported infections](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1383.md)

## Description of the risk

Potential difference in protection against re-infections based on symptomatic status in initial infection.

## Is the risk affecting GBN scales

* [Yes](https://github.com/mm80843/T3.5/blob/pages/ISO_Scale/PBN__ISO_Scale_1.md)

## Mitigations of this risk

* [Evaluate the difference in efficacy between symptomatic and asymptomatic individuals.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_2513.md)

## Name of the risk

Uncertainty in the efficacy of protection against re-infections in symptomatic and asymptomatic individuals.

## People affected by this risk

* [Re-infected individuals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1292.md)

## Stakeholders who can mitigate this risk

* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)

## Technologies linked to the risk

* [Research and data analysis technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1310.md)

## Type of impact of the risk (according to ISO37100)

* [Health and care](https://github.com/mm80843/T3.5/blob/pages/ISO_Purpose/PBN__ISO_Purpose_0.md)

## Type of purpose of the risk (according to ISO37100)

* [Health and care](https://github.com/mm80843/T3.5/blob/pages/ISO_Impact/PBN__ISO_Impact_3.md)

## Type of the risk

* [Physical](https://github.com/mm80843/T3.5/blob/pages/RiskHealth/PBN__RiskHealth_0.md)

## Property: has_RiskType

* [Medical](https://github.com/mm80843/T3.5/blob/pages/RiskType/PBN__RiskType_15.md)

